Richter E, Weigel H, Barz D, Krause K P, Matthes G
Institut für Transfusiologie und transplantologie, Humboldt-Universität zu Berlin.
Beitr Infusionsther. 1991;28:213-5.
We present a case report of the transfusion of cryopreserved HPA 1-negative platelets to a newborn suffering from neonatal alloimmune thrombocytopenia (NAT). A boy weighing 3450 g, born of a HPA1-negative mother with a platelet count of 9 Gpt/l after delivery, received two transfusions of cryopreserved HPA1-negative platelet concentrates. The first transfusion resulted in a platelet increment to 32 Gpt/l (CCI 11). A second transfusion was needed after a further drop of the platelet count on day 4 to 18 Gpt/l, resulting in an increment to 64 Gpt/l (CCI 36). Normal development during the first six months was obtained. In our opinion, cryopreserved HPA1-negative platelets could be helpful in the therapeutical strategy of NAT.
我们报告了一例为患有新生儿同种免疫性血小板减少症(NAT)的新生儿输注冷冻保存的HPA 1阴性血小板的病例。一名体重3450克的男婴,其母亲为HPA1阴性,出生后血小板计数为9 Gpt/l,接受了两次冷冻保存的HPA1阴性血小板浓缩液输血。第一次输血后血小板计数增至32 Gpt/l(校正计数增量为11)。在第4天血小板计数进一步降至18 Gpt/l后,需要进行第二次输血,结果血小板计数增至64 Gpt/l(校正计数增量为36)。婴儿在前六个月发育正常。我们认为,冷冻保存的HPA1阴性血小板可能有助于NAT的治疗策略。